HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Clonazepam, baclofen and placebo in the treatment of spasticity.

Abstract
25 patients with multiple sclerosis (MS) and other spastic disorders, 33 MS patients and 10 control patients with MS were given clonazepam, baclofen or placebo over a period of 5 days to 20 weeks. Both clonazepam and baclofen were significantly more effective than placebo in the treatment of spasticity (p less than 0.005 or p less than 0.01). A clinical trial of clonazepam versus baclofen was carried out and this showed no significant difference between the two drugs. However, there was indication that clonazepam influenced with better improvement in patients with slight muscle hypertonia mainly of cerebral origin. Patients with more severe forms, mainly of spinal spasticity, benefited rather from baclofen treatment (Fisher's test, p = 0.003). There was suggestion that combination of the two drugs may be more effective in some patients than than clonazepam or baclofen alone.
AuthorsW Cendrowski, W Sobczyk
JournalEuropean neurology (Eur Neurol) Vol. 16 Issue 1-6 Pg. 257-62 ( 1977) ISSN: 0014-3022 [Print] Switzerland
PMID354938 (Publication Type: Clinical Trial, Comparative Study, Controlled Clinical Trial, Journal Article)
Chemical References
  • Aminobutyrates
  • Benzodiazepinones
  • Placebos
  • Clonazepam
  • Baclofen
Topics
  • Adolescent
  • Adult
  • Aged
  • Aminobutyrates (therapeutic use)
  • Baclofen (therapeutic use)
  • Benzodiazepinones (therapeutic use)
  • Clinical Trials as Topic
  • Clonazepam (therapeutic use)
  • Drug Evaluation
  • Female
  • Humans
  • Male
  • Middle Aged
  • Multiple Sclerosis (drug therapy)
  • Placebos
  • Spasm (drug therapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: